Spinal Cord Stimulation for Peripheral Neuropathy

Palo Alto (17 mi)

Overseen byMatthew Chung, MD

Age: 18+

Sex: Any

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: N/A

Waitlist Available

Sponsor: M.D. Anderson Cancer Center

No Placebo Group

Trial Summary

What is the purpose of this trial?To explore the benefits of using closed loop spinal cord stimulation (SCS) in the treatment of patients experiencing painful chemotherapy induced peripheral neuropathy (CIPN) by assessing changes in pain, quality of life, pain medication use, sensory improvement through quantitative sensory testing, and improvement of gait through quantitative gait testing.

Eligibility Criteria

This trial is for individuals suffering from painful peripheral neuropathy caused by chemotherapy. Participants should have a history of cancer treatment-related nerve pain in their limbs and be seeking relief.

Inclusion Criteria

I am 18 years old or older.

I have nerve damage in my legs due to chemotherapy.

Exclusion Criteria

I am currently being treated with antibiotics for an active infection.

I have cancer that has spread to my brain.

I am currently receiving chemotherapy or immunotherapy.

Treatment Details

The study tests the effectiveness of a spinal cord stimulator implant to alleviate pain, improve life quality, reduce pain medication use, enhance sensory function, and better gait in patients with chemotherapy-induced nerve damage.

1Treatment groups

Experimental Treatment

Group I: SCS ImplantationExperimental Treatment1 Intervention

Participants will be screened on a weekly basis in the Pain Management Clinic